CARDIOVASCULAR JOURNAL OF AFRICA: VOLUME 18, ISSUE
3, MAY 2007
Title: South African lamb and
cardiovascular disease risk : editorial
Authors: Delport, R.; Schonfeldt, H.C.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 136-138
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: Dysrhythmogenic potential in
acute admissions to psychiatric hospitals and
clinics : cardiovascular topic
Authors: Grant, C.C.; Steenkamp, B.; Gauche, L.;
Becker, P.J.; Ker, J.; Roos, J.L.; Viljoen, M.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 140-144
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: Co-morbidity between physical disease,
especially cardiovascular, and psychological
disturbances is well documented. in psychiatric
patients, the potential for dysrhythmogenic
incidences is increased by the fact that many
psychiatric medications influence cardiovascular
function.
Aim: The aim of the study was to examine the
dysrhythmogenic potential of 30 psychiatric
patients (group A), irrespective of diagnoses or
medication, at admission to psychiatric
institutions.
Methods: The dysrhythmogenic potential was
determined in terms of heart rate-corrected QT
intervals (QTc), heart rate-corrected JT
intervals (JTc), QT and JT dispersion (QTcd and
JTcd) between leads v1 and v6, and heart rate
variability (HRV) as determined from lead v6 of
the ECG. values were compared with 30 age- and
gender-matched controls (group B). in the second
part of the study the dysrhythmogenic indicators
were assessed in a patient group (group C; n 5
43) with only psychiatric disorders and compared
to a group with psychiatric as well as medical
disorders (group D; n 5 27).
Results: The patient group A had significantly
higher values than the control group for mean
QTc (v6) (0.4579 + 0.0328 vs 0.4042 + 0.0326; p
5 0.0470), mean JTc (v6) (0.3883 + 0.0348 vs
0.3064 + 0.0271; p 5 0.0287) and mean QT and JT
dispersion values (QTcd 5 0.0443 + 0.0203 vs
0.0039 + 0.0053 and JTcd 5 0.0546 + 0.1075 vs
0.0143 + 0.1450, p < 0.05). A statistically
significant difference (p < 0.0001) was found
between the patients' (group A) HRV and that of
the controls (group B). No statistically
significant differences were found between the
values of the dysrhythmogenic indicators for
patients with only psychiatric illness (group C)
and those with psychiatric as well as medical
disorders (group D).
Conclusions: Psychiatric patients at the point
of admission to psychiatric institutions may
have an increased dysrhythmogenic potential, not
necessarily caused by physical disease. The
potential of an augmented risk for
cardiovascular incidents in psychiatric patients
should be considered when treating such
patients.
Title: The William Nelson ECG Quiz
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 145, 168
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: Long-term follow-up of
R403WMYH7 and R92WTNNT2 HCM families : mutations
determine left ventricular dimensions but not
wall thickness during disease progression :
cardiovascular topic
Authors: Revera, Miriam; Van der Merwe, Lize;
Heradien, Marshall; Goosen, Althea; Corfield,
Valerie A.; Brink, Paul A.; Moolman-Smook,
Johanna C.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 146-153
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: Background: The clinical profile and
prognosis of patients with hypertrophic
cardiomyopathy, a primary cardiac muscle disease
caused mostly by mutations in sarcomeric
protein-encoding genes, have been linked to
particular disease-causing mutations in the
past. However, such associations are often based
on cross-sectional observations, as longitudinal
studies of the progression of the disease in
genotypically defined patients are sparse. Most
importantly, the relative contribution of age,
gender and genetic cause to disease profile and
progression has not yet been reported, and the
question remains whether one or more of these
factors could mask the effect of the other(s).
Methods: We previously described cross-sectional
family studies of two hypertrophic
cardiomyopathy (HCM)-causing mutations,
R92WTNNT2 and R403WMYH7, both associated with
minimal hypertrophy, but with widely different
life expectancies. We re-investigated 22 and 26
R92WTNNT2 and R403WMYH7 mutation carriers in
these and additional South African R92WTNNT2
families after a mean 11.08 + 2.79 years, and
compared the influence of the two mutations, in
the context of age and gender, on disease
progression.
Results: We demonstrated a positive correlation
between age and interventricular septal
thickness for both mutations, with more than a
third of all mutation carriers developing
clinically recognised hypertrophy only after the
age of 35 years. This period of hypertrophically
silent HCM also coincided with the years in
which most sudden cardiac deaths occurred,
particularly in male R92WTNNT2 carriers.
Statistical analyses indicated that the
particular mutation was the strongest
determinant of left ventricular remodelling;
particularly, LVESD increased and Ef reduction
was noted in the majority of R403WMYH7 carriers,
which may require clinical follow-up over the
longer term.
Conclusions: Statistical modelling of follow-up
data suggests that an interplay between
unidentified, possibly genderassociated factors,
and the causal mutation are the determinants of
eventual cardiac function and survival, but not
of the extent of hypertrophy, and emphasises the
need for long-term follow-up even in individuals
with apparently mild disease.
Title: Effects of enhanced external
counterpulsation on anginal symptoms and
improvements in objective measures of myocardial
ischaemia : cardiovascular topic
Authors: Yavari, M.; Montazeri, H.R.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 154-156
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: Background: Enhanced external
counterpulsation (EECP) is a novel, potentially
beneficial adjunct therapy used for angina
pectoris. We assessed the efficacy of this
method in relieving angina and improving
objective measures of myocardial ischaemia.
Methods: All patients (67) who referred for EECP
to Shahid Chamran Hospital, Isfahan, Iran from
2002 to 2005 were included. Demographic data,
coronary artery disease (CAD) risk factors and
baseline angiographic data were collected.
Anginal symptoms, Canadian Cardiovascular
Society (CCS) functional class,
echocardiographic parameters (ejection fraction,
left ventricular end-diastolic and end-systolic
diameters) and exercise test duration before and
after the treatment were compared.
Results: Seventy-seven per cent of patients who
had undergone EECP had a positive clinical
response. Exercise test duration and CCS
functional class improved after the treatment.
However, EECP had no significant effect on
echocardiographic parameters. Efficacy was
independent of age, gender, CAD risk factors,
prior CCS functional class and echocardiographic
parameters. Patients without left main artery
involvement and those who had at least one
non-obstructed artery demonstrated a greater
likelihood of improvement.
Conclusion: The results of this study suggested
that EECP is a safe, well tolerated, and
significantly effective treatment for angina
pectoris.
Title: Mitral valve apparatus :
echocardiographic features predicting the
outcome of percutaneous mitral balloon valvotomy
: cardiovascular topic
Authors: Du Toit, R.; Brice, E.A.W.; Van
Niekerk, J.D.; Doubell, A.F.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 159-164
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: Objectives: To evaluate the
significance of involvement of subvalvular
apparatus in the outcome of percutaneous mitral
balloon valvotomy (PMBV) in patients with mitral
stenosis (MS) and to determine the predictive
value of chordal length compared with current
echocardiographic scores.
Methods: Patients with significant MS were
selected according to the Massachusetts General
Hospital score (MGHS). Chordal lengths were
assessed as additional markers of disease.
Standard percutaneous valvotomies were
performed. valve area was assessed
post-procedure with follow-up over one year.
Results: Thirty-nine patients were prospectively
studied. valve area increased from a mean (SD)
0.97 (0.26) cm2 to 1.52 (0.38) cm2 with
procedural success in 31 (79.5%) patients. There
was no correlation (r 5 0.09) between the MGHS
and final valve area (FVA). There was a positive
correlation between anterior chordal length and
FVA (r 5 0.66; p 5 0.01). An FVA > 1.5 cm2 was
associated with higher mean chordal lengths (p 5
0.01). A positive correlation wasseen between
valve area pre-procedure and FVA (r 5 0.61; p <
0.01).
Conclusions: The MGHS is valuable in the
selection of patients for PMBV, but fails to
separate selected patients into prognostic
groups. Assessment of chordal length provides
useful additional information, predicting the
outcome of PMBV more accurately. our data may
support the earlier use of PMBV (asymptomatic
patients).
Title: Effect of heterozygous
b-thalassaemia trait on coronary atherosclerosis
via coronary artery disease risk factors : a
preliminary study : cardiovascular topic
Authors: Hashemi, M.; Shirzadi, E.; Talaei, Z.;
Moghadas, L.; Shaygannia, I.; Yavari, M.; Amiri,
N.; Taheri, H.; Montazeri, H.; Shamsolkottabi,
H.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 165-168
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: Background: Thalassaemia is considered
the most common genetic disorder worldwide. An
association between the heterozygous
b-thalassaemia trait and myocardial infarction
has previously been observed. However, the
relationship between heterozygous b-thalassaemia
and atherosclerosis, considering other coronary
artery disease (CAD) risk factors, has remained
unclear.
Methods: A case-control study was conducted to
evaluate the hypothesis that thalassaemia minor
affects the likelihood of atherosclerotic plaque
formation. Blood counts and blood chemistry data
as well as traditional risk factors from 1 363
patients referred to heart centres for coronary
angiography were recorded. Heterozygous
b-thalassaemia was diagnosed by the presence of
hypochoromic-microcytic anaemia, ferritin levels
> 12 ng/ml and haemoglobin-A2 levels > 3.5.
Results: Chi-squared analysis showed that the
prevalence of heterozygous b-thalassaemia was
not significantly different between patients
with and without CAD (p > 0.05). Multivariate
logistic regression analysis using CAD as the
dependent variable and traditional risk factors,
haematocrit, ferritin levels and heterozygous
b-thalassaemia as independent variables, did not
show any significant difference either.
independent two-tailed student's t-tests showed
that haematocrit levels were statistically
different (p = 0.000) between CAD+ and CAD-
groups, but low-density lipids (LDL),
high-density lipids (HDL), triglycerides (TG),
total cholesterol and serum ferritin levels were
not statistically different (p > 0.05).
Conclusion: The prevalence of heterozygous
b-thalassaemia in the case group was not
significantly different from the control group.
This case-control study did not support the
hypothesis that thalassaemia minor affects the
likelihood of atherosclerotic plaque formation.
Title: CT imaging of myocardial
viability : experimental and clinical evidence :
review article
Authors: Mahnken, Andreas H.; Muhlenbruch,
Georg; Gunther, Rolf W.; Wildberger, Joachim E.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 169-174
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: over the last decade, imaging of
myocardial viability has become a
well-established indication in patients
suffering from myocardial infarction. Myocardial
viability imaging is routinely performed using
F-fluorodeoxyglucose positron emission
tomography, single-photon emission computed
tomography or magnetic resonance imaging. only
recently have several multi-slice spiral
computed tomography (MSCT) techniques been
evaluated for visualisation of myocardial
infarction. This review describes the different
concepts of MSCT viability imaging. MSCT
assessment of myocardial morphology, myocardial
perfusion imaging and delayed myocardial
contrast enhancement are introduced, with the
latter evolving as the key concept of MSCT
viability imaging. Clinical relevance of the
different MSCT techniques is described.
Title: Cardiomyopathy in Africa :
heredity versus environment : review article
Authors: Mayosi, Bongani M.; Somers, Krishna
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 175-179
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: unlike other parts of the world in
which cardiomyopathy is rare, heart muscle
disease is endemic in Africa. The major forms of
cardiomyopathy in Africa are dilated
cardiomyopathy (DCM) and endomyocardial fibrosis
(EMF). Whereas DCM is a major cause of heart
failure throughout the continent, EMF is
restricted to the tropical regions of East,
Central, and West Africa. Although
epidemiological studies are lacking,
hypertrophic cardiomyopathy and arrhythmogenic
right ventricular cardiomyopathy seem to have
characteristics similar to those of other
populations elsewhere in the world.
Recent advances in the genetic analysis of DCM
in other parts of the world indicate that it is
a genetically heterogeneous disorder in which
some cases have a Mendelian cause and others
have a non-genetic or multifactorial cause. This
heterogeneous pattern of inheritance has been
confirmed in small studies that have been
conducted so far in Africa. The advent of human
immunodeficiency virus infection and its
association with cardiomyopathy has emphasised
the role of inflammatory agents in the
pathogenesis of DCM.
By contrast with DCM in which some cases have
major genetic contributions, there is scanty
evidence for the role of genetic factors in the
aetiology of EMF. Although the pathogenesis of
EMF is not fully understood, it appears that the
conditioning factor may be geography (in its
widest sense, to include climate and
socio-economic status), the triggering factor
may be an as yet unidentified infective agent,
and the perpetuating factor may be eosinophilia.
There is a need for renewed effort to identify
genetic and non-genetic factors in EMF and other
forms of heart muscle disease that are prevalent
on the continent of Africa.
Title: Thoracic aortic aneurysm :
direct sign of rupture : case report
Authors: Marijon, Eloi; Vilanculos, Alda;
Tivane, Adriano; Jani, Dinesh; Mocumbi, Ana
Olga; Ferreira, Beatriz; Fressonnet, Renaud
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 180-181
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Abstract: Hypertension, wall thinning and aortic
enlargement are the most important factors
increasing wall stress and causing aortic
aneurysms to rupture. Computed tomography,
especially with contrast image enhancement,
usually shows the aortic anatomy with great
clarity and distinguishes a ruptured aortic
aneurysm from an acute aortic syndrome.
Title: Cardiovascular Healing,
editors : Johann Bauersacks, Stefan Frats : book
review
Authors: Brink, Andries
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 181
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: Vitamin D - the forgotten
vitamin - and the cardiovascular physician :
cardiovascular prescriber
Authors: Brink, A.
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 182-184
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: ONTARGET to provide new
treatment strategies for high-risk
cardiovascular patients : drug trends in
cardiology
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 186-187
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: Cardiologists set to become
obesity experts? : drug trends in cardiology
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 189
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: Reduced risk of new-onset
diabetes with trandolapril / verapamil-SR in
patients with the metabolic syndrome :
drug trends in cardiology
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 190
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: Special report on the
sanofi-aventis cardiometabolic symposium : drug
trends in cardiology
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 192-195
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: Preventing hypertensive
vascular damage - satellite symposium
Hypertension Congress 2007 sponsored by
sanofi-aventis : drug trends in cardiology
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 203-204
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: FIELD study supports the
value of fenofibrate in type 2 diabetes
management : drug trends in cardiology
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 205
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)
Title: New blood pressure-monitoring
approaches : cardio news
From: Cardiovascular Journal of Africa, Vol 18,
Issue 3, May / Jun
Published: 2007
Pages: 208
Full text: Click here to
order
Full text:
Click
here to read online (Login Required)